Skip to main content

Peer Review reports

From: BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway

Original Submission
1 Sep 2017 Submitted Original manuscript
13 Oct 2017 Reviewed Reviewer Report - Alicia Viloria-Petit
7 Nov 2017 Reviewed Reviewer Report - Niek N Sanders
8 Dec 2017 Author responded Author comments - Melissa Ledet
Resubmission - Version 2
8 Dec 2017 Submitted Manuscript version 2
9 Feb 2018 Reviewed Reviewer Report - Niek N Sanders
1 Mar 2018 Reviewed Reviewer Report - Alicia Viloria-Petit
6 Mar 2018 Author responded Author comments - Melissa Ledet
Resubmission - Version 3
6 Mar 2018 Submitted Manuscript version 3
27 Mar 2018 Reviewed Reviewer Report - Alicia Viloria-Petit
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
29 Mar 2018 Editorially accepted
12 Apr 2018 Article published 10.1186/s12885-018-4323-8

You can find further information about peer review here.

Back to article page